Iron deficiency anaemia
Conditions
Interventions
1. Study setting - Professorial Medical wards or OPD clinics of the Colombo North teaching hospital, Sri Lanka.
2. Randomization: All consenting males and females will be randomized using a compute
Sponsors
Faculty of Medicine
Eligibility
Inclusion criteria
Inclusion criteria: All consenting adults, both male and female over 18 years of age Confirmed iron deficiency anaemia with a hemoglobin of 10 g/dL or less and serum ferritin below 50 ng/mL
Exclusion criteria
Exclusion criteria: Patients who are hypersensitive to iron therapy (any ferrous compound) Pregnant and Lactating women Patients with other comorbidities that cause anaemia of chronic disease (Chronic kidney disease, chronic liver disease, connective tissue diseases and malignancies), Any other condition or therapy, which would make patient unsuitable for the trial (Patients on IV iron, patients with ongoing bleeding, patients with mixed deficiency anaemia, patients with malabsorption syndromes/ bariatric surgery, patients on recurrent blood transfusions, patients with haemoglobinopathies)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The mean change in hemoglobin at week 12 from baseline [Week 12] The mean change in serum ferritin [ Week 12] | — |
Secondary
| Measure | Time frame |
|---|---|
| The proportion of participants who achieved a rise of 2 g/dL or more in haemoglobin at week 12 [Week 12] The mean change in serum ferritin at week 12 from baseline [ week 12] Rate of adverse events (List of adverse events can be found in the attached document - Proposal_R3) [Week 12 ] | — |
Countries
Sri Lanka
Contacts
Public ContactProfessor K. Chamila D. Mettananda
Professor in Pharmacology
Outcome results
None listed